Organic
Organic
批准号:
8335542
负责人:
MICHAEL V. SEIDEN
金额:
$3.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-07-21 至 2014-06-30
关键词:
AffinityAreaBindingBiological ProcessCalendarCellsChemicalsComprehensive Cancer CenterConsultConsultationsCustomDNADevelopmentDoctor of PhilosophyFox Chase Cancer CenterFoxesFundingGrantInstructionLabelLeadershipLigandsMalignant NeoplasmsMissionOrganic Synthesis FacilityPeer ReviewPharmaceutical PreparationsPhotosensitizing AgentsProdrugsProductivityProtein BindingProteinsPublicationsReagentResearchResearch PersonnelResearch Project GrantsSeasonsSeriesServicesSpecificityStaining methodStainsStructureSystemTamoxifenanalogantibody conjugateanticancer researchbiological researchchemical synthesiscompound 17cost effectivecrosslinkenzyme activityenzyme mechanismenzyme substrate analoginhibitor/antagonistlink proteinmacromoleculemeetingsnovelprogramsprotein functionsmall molecule
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The primary purpose of the Organic Synthesis Facility (OSF) is to produce the highest quality synthetic molecules for Fox Chase Cancer Center (FCCC) investigators. The OSF was used by 19 investigators with peer-reviewed funding in calendar year 2009. Over eighty-five percent (85.4%) of use was in support of peer-reviewed, funded investigators in calendar year 2009. Small organic molecules are used in many areas
of research as specific reagents including those that are inhibitors of enzyme activity or protein binding.
Some of these molecules have been used in the development of prodrugs against target proteins identified at FCCC. Analogues of natural substrates have been used to probe enzyme mechanism, to investigate protein function, or to lest specific hypotheses. The molecules synthesized by the Facility are not purchasable from chemical companies, and custom synthesis from commercial enterprises is either not available or prohibitively expensive. The demand for synthetic services and especially the demand for novel
compound synthesis have increased significantly over this current funding period. In order to meet this need, the efficiency and productivity of the Facility have been increased with the addition of a seasoned Ph.D. chemist to the staff and by acquisition of a new LC-MS system. In addition to increasing efficiency, the LC-MS system provides the Facility with new capabilities and services. During the last grant period
(calendar years 2006-2009), 79 different chemical syntheses were completed including 44 novel compounds for 17 investigators in four Research Programs. The compounds synthesized were very diverse in structure and included a series of tamoxifen analogues, drug-conjugated antibodies, p53 inhibitors, Paki inhibitors, and photosensitizers. The OSF provided analytical, purification and consulting services to 46 investigators from all five Research Programs and seven Shared Facilities during the current funding period. In the last four calendar years (2006-2009), the average number of requests for these analytical and purification services was 59 per month, compared to 34 in calendar years 2000-2004. The large user group of 46 investigators from all five Research Programs and seven Shared Facilities indicates that the materials
produced and services provided by the Facility are necessary for the scientific objectives of a wide range of research projects being carried out throughout the Center.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Senior Leadership
-
批准号:8518889
-
项目类别:
-
资助金额:$14.0万
-
财政年份:2012
-
负责人:MICHAEL V. SEIDEN
-
依托单位:
Senior Leadership
-
批准号:8539988
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2012
-
负责人:MICHAEL V. SEIDEN
-
依托单位:
Senior Leadership
-
批准号:8532130
-
项目类别:
-
资助金额:$17.0万
-
财政年份:2012
-
负责人:MICHAEL V. SEIDEN
-
依托单位:
Senior Leadership
-
批准号:8518551
-
项目类别:
-
资助金额:$11.55万
-
财政年份:2012
-
负责人:MICHAEL V. SEIDEN
-
依托单位:
Molecular
-
批准号:8335541
-
项目类别:
-
资助金额:$2.67万
-
财政年份:2011
-
负责人:MICHAEL V. SEIDEN
-
依托单位:
Genomics
-
批准号:8335549
-
项目类别:
-
资助金额:$13.82万
-
财政年份:2011
-
负责人:MICHAEL V. SEIDEN
-
依托单位:
Protocol Review
-
批准号:8335553
-
项目类别:
-
资助金额:$7.97万
-
财政年份:2011
-
负责人:MICHAEL V. SEIDEN
-
依托单位:
Planning and Evaluation
-
批准号:8335531
-
项目类别:
-
资助金额:$3.54万
-
财政年份:2011
-
负责人:MICHAEL V. SEIDEN
-
依托单位:
DNA Facility
-
批准号:8335539
-
项目类别:
-
资助金额:$3.26万
-
财政年份:2011
-
负责人:MICHAEL V. SEIDEN
-
依托单位:
Developmental
-
批准号:8335532
-
项目类别:
-
资助金额:$34.54万
-
财政年份:2011
-
负责人:MICHAEL V. SEIDEN
-
依托单位:
High Throughout Facility
-
批准号:8335540
-
项目类别:
-
资助金额:$7.28万
-
财政年份:2011
-
负责人:MICHAEL V. SEIDEN
-
依托单位:
Biological
-
批准号:8335543
-
项目类别:
-
资助金额:$5.38万
-
财政年份:2011
-
负责人:MICHAEL V. SEIDEN
-
依托单位:
Cell Sorting
-
批准号:8335545
-
项目类别:
-
资助金额:$2.33万
-
财政年份:2011
-
负责人:MICHAEL V. SEIDEN
-
依托单位:
Protocol Specific
-
批准号:8335554
-
项目类别:
-
资助金额:$8.76万
-
财政年份:2011
-
负责人:MICHAEL V. SEIDEN
-
依托单位:
Histopathology
-
批准号:8335547
-
项目类别:
-
资助金额:$6.51万
-
财政年份:2011
-
负责人:MICHAEL V. SEIDEN
-
依托单位:
Administration
-
批准号:8335535
-
项目类别:
-
资助金额:$16.35万
-
财政年份:2011
-
负责人:MICHAEL V. SEIDEN
-
依托单位:
Senior Leadership
-
批准号:8335529
-
项目类别:
-
资助金额:$216.36万
-
财政年份:2011
-
负责人:MICHAEL V. SEIDEN
-
依托单位:
Program Leaders
-
批准号:8335536
-
项目类别:
-
资助金额:$13.41万
-
财政年份:2011
-
负责人:MICHAEL V. SEIDEN
-
依托单位:
Biostats
-
批准号:8335550
-
项目类别:
-
资助金额:$22.54万
-
财政年份:2011
-
负责人:MICHAEL V. SEIDEN
-
依托单位:
Cell Culture
-
批准号:8335544
-
项目类别:
-
资助金额:$12.09万
-
财政年份:2011
-
负责人:MICHAEL V. SEIDEN
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: